[go: up one dir, main page]

AU2003302109A1 - Prodrug esters of ceftriaxone - Google Patents

Prodrug esters of ceftriaxone

Info

Publication number
AU2003302109A1
AU2003302109A1 AU2003302109A AU2003302109A AU2003302109A1 AU 2003302109 A1 AU2003302109 A1 AU 2003302109A1 AU 2003302109 A AU2003302109 A AU 2003302109A AU 2003302109 A AU2003302109 A AU 2003302109A AU 2003302109 A1 AU2003302109 A1 AU 2003302109A1
Authority
AU
Australia
Prior art keywords
ceftriaxone
prodrug esters
prodrug
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003302109A
Inventor
Ram Chander Aryan
Yatendra Kumar
Vandana RAINA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2003302109A1 publication Critical patent/AU2003302109A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003302109A 2002-11-21 2003-11-21 Prodrug esters of ceftriaxone Abandoned AU2003302109A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1175/DEL/2002 2002-11-21
IN1175DE2002 2002-11-21
PCT/IB2003/005327 WO2004046153A1 (en) 2002-11-21 2003-11-21 Prodrug esters of ceftriaxone

Publications (1)

Publication Number Publication Date
AU2003302109A1 true AU2003302109A1 (en) 2004-06-15

Family

ID=32321381

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003302109A Abandoned AU2003302109A1 (en) 2002-11-21 2003-11-21 Prodrug esters of ceftriaxone

Country Status (2)

Country Link
AU (1) AU2003302109A1 (en)
WO (1) WO2004046153A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CN102471248B (en) * 2009-08-10 2015-01-07 Bhi有限合伙公司 Methods, compounds, and compositions for delivering 1,3-propan ed isulfonic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188781B1 (en) * 1984-12-28 1990-10-24 Merck & Co. Inc. 1-oxa-1-dethia-cephalosporin compounds and antibacterial agent comprising the same
EP0791597B1 (en) * 1996-02-21 2000-07-12 Lupin Laboratories Limited Method for manufacture of cephalosporins and intermediates thereof
IT1286494B1 (en) * 1996-11-19 1998-07-15 Hichem Pharma S P A PROCEDURE FOR THE PREPARATION OF CEPHALOSPORANIC DERIVATIVES
AU3967000A (en) * 1999-04-15 2000-11-02 Biochemie Gesellschaft Mbh Beta-lactam production

Also Published As

Publication number Publication date
WO2004046153A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
AU2003226373A1 (en) 5-alkyl-7-alkylcarbonate-isoflavone ester as isoflavone prodrug
AU2003202924A1 (en) Variation of neural-stimulation parameters
AU2003234718A1 (en) Instrument introducer
AU2003202259A1 (en) Lipid compositions, production thereof and of esters
AU2003277903A1 (en) Novel stabilized cinnamic ester sunscreen compositions
AU2003287509A1 (en) Methods of manipulating small amounts of solids
AU2002952384A0 (en) Structures
AU2003267638A1 (en) Endoscope
AU2003255310A1 (en) Silicas
AU2003236991A1 (en) Representations of processes
AU2003245800A1 (en) Flavourant compounds
AU2003222083A1 (en) Acid and ester compounds and methods of using the same
AU2003230395A1 (en) Micro-support structures
AU2003206803A1 (en) Production of alkenones
AU2003225891A1 (en) 6"-amino-6"-deoxygalactosylceramides
AU2003224051A1 (en) Watersoluble prodrugs of propofol
AU2003288237A1 (en) Artificial esterases
AU2003209453A1 (en) Transposon
AU2003302109A1 (en) Prodrug esters of ceftriaxone
AU2003290763A1 (en) Modulation of jumonji expression
AU2003266271A1 (en) Regulation of human esterase
AU2003262152A1 (en) Endoscope
AU2003228883A1 (en) Neopentylglycol bis (diarylphosphate) esters
AU2003294268A1 (en) Candle mixtures comprising naturally derived alkyl esters
AU2003258716A1 (en) Tocopheryl ester

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase